|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 498/14 | |
| A61K 47/48 | |||
| G01N 33/50 | |||
| A61K 31/5383 |
| (11) | Patento numeris | 2240495 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09707128.6 |
| Europos patento paraiškos padavimo data | 2009-01-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-10-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-07-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2009/031199 |
| Data | 2009-01-16 |
| (87) | Numeris | WO 2009/099741 |
| Data | 2009-08-13 |
| (30) | Numeris | Data | Šalis |
| 25504 | 2008-02-01 | US |
| (72) |
COHEN, Robert L., US
HA, Edward Hyungsuk, US
REYNOLDS, Mark E., US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080,
US
|
| (54) | NEMORUBICIN METABOLITE AND ANALOG REAGENTS, ANTIBODY-DRUG CONJUGATES AND METHODS |
| NEMORUBICIN METABOLITE AND ANALOG REAGENTS, ANTIBODY-DRUG CONJUGATES AND METHODS |